{"url_path":"/sec/phio/8-k/2026-07-21/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-21","source_url":"https://www.sec.gov/Archives/edgar/data/1533040/0001437749-26-023916-index.html","accession_number":"0001437749-26-023916","cik":"0001533040","ticker":"PHIO","issuer_name":"Phio Pharmaceuticals Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1533040/0001437749-26-023916-index.html","primary_entity_key":"0001533040","primary_entity_name":"Phio Pharmaceuticals Corp."},"word_count":46,"has_tables":true,"body_markdown":"**Item 8.01. Other Events.**\n\n \n\nOn July 21 2026, the Company issued a press release announcing the appointment of Dr. R. Todd Plott, M.D. to the Board of Directors.\n\n \n\nThe full text of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference."}